Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer SN Malik, M Brattain, PM Ghosh, DA Troyer, T Prihoda, R Bedolla, ... Clinical cancer research 8 (4), 1168-1171, 2002 | 440 | 2002 |
Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer JI Kreisberg, SN Malik, TJ Prihoda, RG Bedolla, DA Troyer, S Kreisberg, ... Cancer research 64 (15), 5232-5236, 2004 | 400 | 2004 |
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead WH Goodson III, L Lowe, DO Carpenter, M Gilbertson, A Manaf Ali, ... Carcinogenesis 36 (Suppl_1), S254-S296, 2015 | 364 | 2015 |
The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it RM Savoy, PM Ghosh Endocrine-related cancer 20 (6), R341-R356, 2013 | 258 | 2013 |
Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer Y Wang, JI Kreisberg, PM Ghosh Current cancer drug targets 7 (6), 591-604, 2007 | 172 | 2007 |
Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation R Bedolla, TJ Prihoda, JI Kreisberg, SN Malik, NK Krishnegowda, ... Clinical cancer research 13 (13), 3860-3867, 2007 | 172 | 2007 |
Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases RG Bedolla, Y Wang, A Asuncion, K Chamie, S Siddiqui, MM Mudryj, ... Clinical Cancer Research 15 (3), 788-796, 2009 | 162 | 2009 |
Signal transduction pathways in androgen-dependent and-independent prostate cancer cell proliferation PM Ghosh, SN Malik, RG Bedolla, Y Wang, M Mikhailova, TJ Prihoda, ... Endocrine-related cancer 12 (1), 119-134, 2005 | 141 | 2005 |
Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line PM Ghosh, N Ghosh-Choudhury, ML Moyer, GE Mott, CA Thomas, ... Oncogene 18 (28), 4120-4130, 1999 | 124 | 1999 |
Akt in prostate cancer: possible role in androgen-independence PM Ghosh, S Malik, R Bedolla, JI Kreisberg Current drug metabolism 4 (6), 487-496, 2003 | 121 | 2003 |
Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival Y Wang, M Mikhailova, S Bose, CX Pan, RWV White, PM Ghosh Oncogene 27 (56), 7106-7117, 2008 | 120 | 2008 |
Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins M Roy, HJ Kung, PM Ghosh American journal of cancer research 1 (4), 542, 2011 | 118 | 2011 |
Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells N Ghosh-Choudhury, G Ghosh-Choudhury, A Celeste, PM Ghosh, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1497 (2), 186-196, 2000 | 117 | 2000 |
Development and characterization of bladder cancer patient-derived xenografts for molecularly guided targeted therapy C Pan, H Zhang, CG Tepper, T Lin, RR Davis, J Keck, PM Ghosh, P Gill, ... PloS one 10 (8), e0134346, 2015 | 103 | 2015 |
The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence BA Mooso, RL Vinall, M Mudryj, SA Yap, RWV White, PM Ghosh The Journal of urology 193 (1), 19-29, 2015 | 98 | 2015 |
A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells Y Wang, JI Kreisberg, RG Bedolla, M Mikhailova, RW deVere White, ... Oncogene 26 (41), 6061-6070, 2007 | 98 | 2007 |
Targeting ErbB3: the new RTK (id) on the prostate cancer block M K. Jathal, L Chen, M Mudryj, P M. Ghosh Immunology, Endocrine & Metabolic Agents-Medicinal ChemistryCurrent …, 2011 | 95 | 2011 |
Monitoring electropermeabilization in the plasma membrane of adherent mammalian cells PM Ghosh, CR Keese, I Giaever Biophysical Journal 64 (5), 1602-1609, 1993 | 89 | 1993 |
Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells PM Ghosh, GE Mott, N Ghosh-Choudhury, RA Radnik, ML Stapleton, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1359 (1), 13-24, 1997 | 87 | 1997 |
Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor PM Ghosh, M Mikhailova, R Bedolla, JI Kreisberg American Journal of Physiology-Renal Physiology 280 (6), F972-F979, 2001 | 84 | 2001 |